enGene Therapeutics Inc. (ENGN) › Total LiabilitiesenGene Therapeutics Inc. (ENGN) — Total LiabilitiesAnnual figures by period end, from SEC filings.2022-10-31: $47.41M2023-10-31: $14.47M2024-10-31: $38.56M2025-10-31: $53.76M$53.76M2022-10-31Total Liabilities (USD)2025-10-31Period endedTotal LiabilitiesChange YoYSource filing2025-10-31$53.76M+39.4%2025-12-22Balance as of period end2024-10-31$38.56M+166.4%2025-12-22Balance as of period end2023-10-31$14.47M-69.5%2024-12-19Balance as of period end2022-10-31$47.41M—2024-01-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)